Learn more

MOCHIDA PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    168,016
  • Filing trend
    ⇧ 100.0%
About

MOCHIDA PHARMACEUTICAL CO LTD has a total of 27 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 1983. It filed its patents most often in Australia, Taiwan and Serbia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are MOCHIDA PHARM CO LTD, SPIROGEN SARL and WYETH HOLDINGS CO.

Patent filings in countries

World map showing MOCHIDA PHARMACEUTICAL CO LTDs patent filings in countries
# Country Total Patents
#1 Australia 22
#2 Taiwan 4
#3 Serbia 1

Patent filings per year

Chart showing MOCHIDA PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Shirakawa Kamon 6
#2 Makabe Muneyoshi 5
#3 Ohkouchi Munetaka 5
#4 Okano Akihiro 5
#5 Igarashi Tatsuya 3
#6 Kasahara Yasuhiko 3
#7 Minami Akio 3
#8 Kawamura Daisuke 3
#9 Ohzawa Nobuo 3
#10 Iwasaki Norimasa 3

Latest patents

Publication Filing date Title
TW201836637A Liquid pharmaceutical agent comprising antibody characterized by realizing the stability of dimer formation inhibition and deamidation inhibition during long-term storage and being suitable for a wide range of antibody concentration
AU2016319444A1 Freeze-dried alginic acid preparation
TW201626988A Self-emulsifying composition of ω3 fatty acid
TW201938143A Self-emulsifying formulation and self-emulsifying composition of [omega]3 fatty acid exhibiting excellent self-emulsifying property, composition dispersing ability, emulsification stability and absorbability
AU2013204006A1 Composition for treatment of cartilage disease
AU2012256683A1 Diagnosis of respiratory tract infectious diseases using urine specimens
AU2010336225A1 Novel 3-hydroxy-5-arylisothiazole derivative
AU2010312365A1 Novel 3-hydroxy-5-arylisoxazole derivative
AU7333296A Meltrins